IL1A and neoplasm: We found that IL‐1α treatment whether in free form or encapsulated all exhibited similar tumor growth inhibition compared to Blank‐MPs and saline controls (Figure 6a), suggesting that the use of CPH:SA MPs did not significantly suppress the anti‐tumor effects of IL‐1α.